GPT and metabolic dysfunction-associated steatotic liver disease: Studies have shown that elevated ALT could act as an independent component in the occurrence of metabolic complications.24 Overall, in the current study, 152 (39.6%) participants had elevated ALT and those having NAFLD had a higher proportion of participants with raised ALT compared to those without NAFLD (53.0% versus 18.2%, p < 0.0001).